CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 174 enrolled
Drug / intervention
Pentoxifylline +1 moredrug
Likely dose
Pentoxifylline 400mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01382303
NCT01382303Phase 4Completed
CompareCT.gov

Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients : Prospective, Randomized, Double Blinded Active Control, Multicenter Study

Ajou University School of Medicine·interventional·Posted Jun 27, 2011·Updated Jun 16, 2017

In Brief

A Phase 4 clinical trial evaluating Pentoxifylline and Placebo for Type 2 Diabetes. Completed, enrolled 174 participants across 1 site.

Detailed Summary

This multi-center, randomized controlled study aims to evaluate the effects of pentoxifylline on proteinuria in Korean type 2 diabetic patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesSouth Korea
CollaboratorsBundang CHA Hospital, Hallym University Medical Center, Gangnam Severance Hospital, Yonsei University, Myongji Hospital

Timeline

Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedJun 27, 2011
Enrollment StartOct 25, 2010
Primary CompletionDec 20, 2013
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 15.0 years ago

Interventions

Pentoxifyllinedrug

Pentoxifylline 400mg three times a day

Placebodrug

placebo tablet three times a day